載入...
Lurasidone Ingestions Reported to Texas Poison Centers
Background: Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia in 2010. There is limited information on potentially toxic events involving lurasidone outside of clinical investigations. Objective: This investigation describes potentially toxic lurasidone ingestions f...
Na minha lista:
| 發表在: | J Pharm Technol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990146/ https://ncbi.nlm.nih.gov/pubmed/34860899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514533305 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|